ABSTRACT
Endometrial polyps Friable vascular network. May contain foci of hyperplasia or cancer
Chronic endometritis Inflamed, fragile endometrium associated with IUCD use, pelvic inflammatory disease and retained products of conception
Atrophic endometrium Fragile vascular support provided by thin underlying stroma resulting in superficial petechial haemorrhages and mucosal ulceration
Hormone replacement therapy Unstable endometrium (inadequate progestogenic support). Consider poor compliance, variable gastrointestinal absorption and drug interactions. Increased prevalence of polyps
Coagulation defects/anticoagulation Propensity to bleeding from endometrial (e.g. warfarin) vessels
Figure 6.1 Clinical process.
